Benzinga
Benzinga’s Top Ratings Upgrades, Downgrades For February 2, 2021
Upgrades According to Summit Insights Group, the prior rating for ON Semiconductor Corp (NASDAQ:ON) was changed from Hold to Buy. For the fourth quarter, ON Semiconductor had an EPS of $0.35, compared to year-ago quarter EPS of $0.30. The current stock performance of ON Semiconductor shows a 52-week-high of $39.43 and a 52-week-low of $8.17. Moreover, at the end of the last trading period, the closing price was at $36.71. Barclays upgraded the previous rating for Dr Reddy’s Laboratories Ltd (NYSE:RDY) from Equal-Weight to Overweight. Dr Reddy’s Laboratories earned $0.02 in the third quarter, compared to $0.63 in the year-ago quarter. The stock has a 52-week-high of $73.50 and a 52-week-low of $33.33. At the end of the last trading period, Dr Reddy’s Laboratories closed at $59.17. For Palo Alto Networks Inc (NYSE:PANW), Credit Suisse upgraded the previous rating of Neutral to Outperform. For the first quarter, Palo Alto Networks had an EPS of $1.62, compared to year-ago quarter EPS of $1.05. The stock has a 52-week-high of $375.00 and a 52-week-low of $125.47. At the end of the last trading period, Palo Alto Networks closed at $361.58. Evercore ISI Group upgraded the previous rating for Tetra Technologies Inc (NYSE:TTI) from Underperform to Outperform. In the third quarter, Tetra Technologies showed an EPS of $0.09, compared to $0.02 from the year-ago quarter. At the moment, the stock has a 52-week-high of $1.62 and a 52-week-low of $0.22. Tetra Technologies closed at $1.52 at the end of the last trading period. Goldman Sachs upgraded the previous rating for Dell Technologies Inc (NYSE:DELL) from Neutral to Buy. Dell Technologies earned $2.03 in the third quarter, compared to $1.75 in the year-ago quarter. The current stock performance of Dell Technologies shows a 52-week-high of $77.72 and a 52-week-low of $25.51. Moreover, at the end of the last trading period, the closing price was at $74.00. According to Credit Suisse, the prior rating for Rio Tinto PLC (NYSE:RIO) was changed from Neutral to Outperform. The stock has a 52-week-high of $86.90 and a 52-week-low of $35.35. At the end of the last trading period, Rio Tinto closed at $78.48. See all analyst ratings upgrades. Downgrades Credit Suisse downgraded the previous rating for BHP Group Ltd (NYSE:BHP) from Outperform to Neutral. The current stock performance of BHP Group shows a 52-week-high of $74.41 and a 52-week-low of $29.78. Moreover, at the end of the last trading period, the closing price was at $68.38. For Limelight Networks Inc (NASDAQ:LLNW), Cowen & Co. downgraded the previous rating of Outperform to Market Perform. Limelight Networks earned $0.01 in the third quarter, compared to $0.01 in the year-ago quarter. At the moment, the stock has a 52-week-high of $8.19 and a 52-week-low of $3.43. Limelight Networks closed at $4.67 at the end of the last trading period. Compass Point downgraded the previous rating for Hilltop Holdings Inc (NYSE:HTH) from Buy to Neutral. For the fourth quarter, Hilltop Holdings had an EPS of $1.30, compared to year-ago quarter EPS of $0.54. The current stock performance of Hilltop Holdings shows a 52-week-high of $33.69 and a 52-week-low of $11.05. Moreover, at the end of the last trading period, the closing price was at $30.85. According to Piper Sandler, the prior rating for argenx SE (NASDAQ:ARGX) was changed from Overweight to Neutral. For the third quarter, argenx had an EPS of $3.96, compared to year-ago quarter EPS of $0.72. The current stock performance of argenx shows a 52-week-high of $321.66 and a 52-week-low of $103.75. Moreover, at the end of the last trading period, the closing price was at $317.40. See all analyst ratings downgrades. Initiations Stephens & Co. initiated coverage on Zix Corp (NASDAQ:ZIXI) with an Overweight rating. The price target for Zix is set to $11.00. In the third quarter, Zix showed an EPS of $0.17, compared to $0.13 from the year-ago quarter. The current stock performance of Zix shows a 52-week-high of $9.46 and a 52-week-low of $2.84. Moreover, at the end of the last trading period, the closing price was at $8.32. MKM Partners initiated coverage on Poshmark Inc (NASDAQ:POSH) with a Buy rating. The price target for Poshmark is set to $88.00. The stock has a 52-week-high of $104.98 and a 52-week-low of $67.18. At the end of the last trading period, Poshmark closed at $73.00. Guggenheim initiated coverage on Phathom Pharmaceuticals Inc (NASDAQ:PHAT) with a Buy rating. The price target for Phathom Pharmaceuticals is set to $60.00. For the third quarter, Phathom Pharmaceuticals had an EPS of $1.02, compared to year-ago quarter EPS of $1.07. The stock has a 52-week-high of $64.54 and a 52-week-low of $22.06. At the end of the last trading period, Phathom Pharmaceuticals closed at $38.49. Wells Fargo initiated coverage on Gracell Biotechnologies Inc (NASDAQ:GRCL) with an Overweight rating. At the moment, the stock has a 52-week-high of $28.88 and a 52-week-low of $20.12. Gracell Biotechnologies closed at $21.81 at the end of the last trading period. Morgan Stanley initiated coverage on Stride Inc (NYSE:LRN) with a Equal-Weight rating. The price target for Stride is set to $27.00. The stock has a 52-week-high of $52.84 and a 52-week-low of $15.06. At the end of the last trading period, Stride closed at $27.20. Jefferies initiated coverage on Gracell Biotechnologies Inc (NASDAQ:GRCL) with a Buy rating. The price target for Gracell Biotechnologies is set to $30.00. At the moment, the stock has a 52-week-high of $28.88 and a 52-week-low of $20.12. Gracell Biotechnologies closed at $21.81 at the end of the last trading period. Morgan Stanley initiated coverage on Chart Industries Inc (NYSE:GTLS) with an Overweight rating. The price target for Chart Industries is set to $135.00. Chart Industries earned $0.80 in the third quarter, compared to $0.77 in the year-ago quarter. At the moment, the stock has a 52-week-high of $143.56 and a 52-week-low of $15.00. Chart Industries closed at $127.54 at the end of the last trading period. With an Outperform rating, SVB Leerink initiated coverage on Cullinan Management Inc (NASDAQ:CGEM). The price target seems to have been set at $52.00 for Cullinan Management. The stock has a 52-week-high of $43.00 and a 52-week-low of $27.01. At the end of the last trading period, Cullinan Management closed at $33.77. With a Buy rating, Citigroup initiated coverage on Clover Health Investments Corp (NASDAQ:CLOV). The price target seems to have been set at $19.00 for Clover Health Investments. The stock has a 52-week-high of $17.24 and a 52-week-low of $13.10. At the end of the last trading period, Clover Health Investments closed at $13.81. Stephens & Co. initiated coverage on Mimecast Ltd (NASDAQ:MIME) with an Overweight rating. The price target for Mimecast is set to $57.00. In the second quarter, Mimecast showed an EPS of $0.32, compared to $0.13 from the year-ago quarter. The current stock performance of Mimecast shows a 52-week-high of $59.48 and a 52-week-low of $25.14. Moreover, at the end of the last trading period, the closing price was at $44.45. Stephens & Co. initiated coverage on Proofpoint Inc (NASDAQ:PFPT) with an Overweight rating. The price target for Proofpoint is set to $165.00. For the third quarter, Proofpoint had an EPS of $0.59, compared to year-ago quarter EPS of $0.49. The current stock performance of Proofpoint shows a 52-week-high of $140.91 and a 52-week-low of $83.81. Moreover, at the end of the last trading period, the closing price was at $130.62. Stephens & Co. initiated coverage on Ping Identity Holding Corp (NYSE:PING) with an Overweight rating. The price target for Ping Identity Holding is set to $40.00. For the third quarter, Ping Identity Holding had an EPS of $0.11, compared to year-ago quarter EPS of $0.13. The current stock performance of Ping Identity Holding shows a 52-week-high of $37.80 and a 52-week-low of $12.02. Moreover, at the end of the last trading period, the closing price was at $30.83. With an Outperform rating, Raymond James initiated coverage on Neurocrine Biosciences Inc (NASDAQ:NBIX). The price target seems to have been set at $163.00 for Neurocrine Biosciences. Neurocrine Biosciences earned $0.97 in the third quarter, compared to $0.90 in the year-ago quarter. The stock has a 52-week-high of $136.26 and a 52-week-low of $72.14. At the end of the last trading period, Neurocrine Biosciences closed at $106.02. With an Overweight rating, Piper Sandler initiated coverage on Gracell Biotechnologies Inc (NASDAQ:GRCL). The price target seems to have been set at $40.00 for Gracell Biotechnologies. At the moment, the stock has a 52-week-high of $28.88 and a 52-week-low of $20.12. Gracell Biotechnologies closed at $21.81 at the end of the last trading period. Piper Sandler initiated coverage on Surgalign Holdings Inc (NASDAQ:SRGA) with an Overweight rating. The price target for Surgalign Holdings is set to $4.00. For the third quarter, Surgalign Holdings had an EPS of $0.11, compared to year-ago quarter EPS of $0.01. At the moment, the stock has a 52-week-high of $3.15 and a 52-week-low of $1.49. Surgalign Holdings closed at $1.70 at the end of the last trading period. With an Overweight rating, Piper Sandler initiated coverage on Nevro Corp (NYSE:NVRO). The price target seems to have been set at $190.00 for Nevro. Nevro earned $0.29 in the third quarter, compared to $0.58 in the year-ago quarter. The current stock performance of Nevro shows a 52-week-high of $188.14 and a 52-week-low of $65.05. Moreover, at the end of the last trading period, the closing price was at $163.86. See all analyst ratings initiations. See more from BenzingaClick here for options trades from BenzingaEarnings Outlook For Axalta Coating SystemsA Preview Of KLA’s Earnings© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Add Comment